Page last updated: 2024-08-26

norverapamil and propranolol

norverapamil has been researched along with propranolol in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pajeva, IK; Wiese, M1
Bailey, DG; Carruthers, SG; Freeman, DJ1
Lennard, MS; McCourty, JC; Silas, JH; Tucker, GT1
Cubeddu, LX; Gross, KM; Halperin, AK; Rogers, JF1
Guerrero, J; Hecht, HS; Hopkins, J; Josephson, MA; Singh, BN1
Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C1
Ducharme, J; Gauvin, C; Morin, PE; Panetta, R; Walles, M1

Trials

2 trial(s) available for norverapamil and propranolol

ArticleYear
Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
    Clinical pharmacology and therapeutics, 1989, Volume: 46, Issue:4

    Topics: Administration, Oral; Adult; Double-Blind Method; Drug Synergism; Hemodynamics; Humans; Male; Physical Exertion; Propranolol; Random Allocation; Verapamil

1989
Comparative effects of oral verapamil and propranolol on exercise-induced myocardial ischemia and energetics in patients with coronary artery disease: single-blind placebo crossover evaluation using radionuclide ventriculography.
    American heart journal, 1982, Volume: 103, Issue:6

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Exercise Test; Heart Rate; Heart Ventricles; Humans; Middle Aged; Propranolol; Radionuclide Imaging; Stroke Volume; Verapamil

1982

Other Studies

5 other study(ies) available for norverapamil and propranolol

ArticleYear
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
    Journal of medicinal chemistry, 2002, Dec-19, Volume: 45, Issue:26

    Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine

2002
The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris.
    British journal of clinical pharmacology, 1988, Volume: 25, Issue:3

    Topics: Adult; Angina Pectoris; Blood Pressure; Drug Therapy, Combination; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Propranolol; Verapamil

1988
Verapamil and propranolol in essential hypertension.
    Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:6

    Topics: Adult; Aged; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Posture; Propranolol; Random Allocation; Verapamil

1984
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Mar-01, Volume: 847, Issue:2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil

2007
Comparison of sub-2-microm particle columns for fast metabolite ID.
    Journal of separation science, 2007, Volume: 30, Issue:8

    Topics: Chromatography, Liquid; Fluoxetine; Humans; Mass Spectrometry; Microsomes, Liver; Molecular Structure; Particle Size; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Verapamil

2007